| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | | Total Revenue | 5,002 | 1,053 | | Cost of Revenue | 20,561 | 307 | | | Gross Profit | (15,559) | 746 | | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 22,382 | 12,511 | | Non Recurring | 21,769 |
-
| | Others | 2,713 | 119 | | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | (62,424) | (11,884) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 644 | 373 | | Earnings Before Interest And Taxes | (61,780) | (11,511) | | Interest Expense | 4,011 | 523 | | Income Before Tax | (65,790) | (12,034) | | Income Tax Expense |
-
|
-
| | Minority Interest | 107 |
-
| | | | Net Income From Continuing Ops | (65,683) | (12,034) | | | Non-recurring Events | | Discontinued Operations | (533) |
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | (66,216) | (12,034) | | Preferred Stock And Other Adjustments | (16,188) | (1,658) | | | Net Income Applicable To Common Shares | ($82,404) | ($13,692) |
|
0.34% Nasdaq 0.00%
Income Statement
